Employee Benefit and Deferred Compensation Plans - Summary of the Changes in Restricted Stock (Details)	9 Months Ended
	Sep. 30, 2023 $ / shares shares
Performance shares
Performance-Based Restricted Stock
Nonvested at beginning of period (in shares) | shares	155,838
Awarded (in shares) | shares	81,867
Vested (in shares) | shares	0
Cancelled (in shares) | shares	0
Nonvested at end of period (in shares) | shares	237,705
Weighted Average Grant-Date Fair Value
Nonvested at beginning balance (in usd per share) | $ / shares	$ 36.23
Awarded (in usd per share) | $ / shares	35.57
Vested (in usd per share) | $ / shares	0
Cancelled (in usd per share) | $ / shares	0
Nonvested at end balance (in usd per share) | $ / shares	$ 36.01
Restricted stock
Performance-Based Restricted Stock
Nonvested at beginning of period (in shares) | shares	680,403
Awarded (in shares) | shares	335,917
Vested (in shares) | shares	(212,574)
Cancelled (in shares) | shares	(31,504)
Nonvested at end of period (in shares) | shares	772,242
Weighted Average Grant-Date Fair Value
Nonvested at beginning balance (in usd per share) | $ / shares	$ 36.23
Awarded (in usd per share) | $ / shares	35.49
Vested (in usd per share) | $ / shares	34.78
Cancelled (in usd per share) | $ / shares	35.67
Nonvested at end balance (in usd per share) | $ / shares	$ 36.33